EPI S (KVS) - peptide bioregulator for the harmonization of the cardiovascular system (heart).

EPI-S BIOONO vascular peptides, 90 capsules, restoration of the cardiovascular system, treatment of blood vessels, disease prevention coronary heart disease, general and cerebral atherosclerosis, hypertension, endarteritis dietary supplement

Peptide bioregulator EPI- S  - to normalize the functioning of the heart and the entire circulatory system, normalize blood pressure and cholesterol levels in the blood.

The bioregulator EPI-S, which also includes natural peptides, has a quick restorative effect for a long time due to targeted effects on various body systems.

The low molecular weight peptides contained in the EPI-S bioregulator act according to the following principle: they connect to cell receptors, for which this becomes a signal to start certain changes. Sometimes, instead of receptors, another target acts, for example, a protein that goes into its active form and starts a cascade of reactions. Whatever it is - a receptor or another target - its interaction with the peptide occurs according to the "key-lock" principle, that is, strictly specific. Peptides are safe, non-toxic and do not cause allergic reactions, are quickly excreted from the body without accumulation, have no side effects and withdrawal syndrome.

Bioregulator EPI-S - has a selective effect on various cells of the vascular wall, normalizes metabolism in cells and regulates the functions of the vascular wall. In particular, the drug activates the regeneration of endothelial tissues, stimulates the differentiation and synthesis of structural and functional proteins of the endothelium. Restores intercellular interactions. Thus, tissue trophism improves, the phenomena of hypoxia, edema, tissue intoxication decrease, metabolic processes normalize, capillary functions and microcirculation are restored.

In a clinical study, the effectiveness of the drug "EPI-S" was established for the complex restoration of the functions of the vascular system after diseases of various origins, in pathological conditions leading to impaired vascular function, when exposed to extreme environmental factors, malnutrition, lipid metabolism disorders, as well as aging. The drug is successfully used to regulate the function of the vascular system in hypertension, atherosclerotic lesions of the vascular wall, coronary heart disease, angiopathy of various origins and cerebrovascular accidents.

Bioregulator EPI-S is recommended for:

• To prevent premature aging
• Normalization of the work of the heart and the entire circulatory system;
• Normalization of blood pressure;
• Normalization of cholesterol levels in the blood;
• Helps with hypertension and hypotension;
• Helps to strengthen the venous wall;
• Atherosclerosis of the vessels of the heart;
• Atherosclerosis and atherosclerosis of the brain
• Obliterating atherosclerosis of the lower extremities
• Lesions of capillary vessels, with pulmonary tuberculosis;
• Vegetovascular dystonia
• With heart weakness;
• Cardiac ischemia
• Heart failure
• Phlebeurysm
• Hypertension
• Myocarditis
• Postinfarction cardiosclerosis
• With edema of cardiac origin;
• With mild and moderate forms of diabetes;
• It is recommended to use during remission to avoid repeated attacks of heart disease.

EPI peptide bioregulators have the ability to:

• Change the properties of the plasma membrane of the cell (permeability to certain substances administered together or in parallel within the framework of the therapeutic regimen),
• Change gene expression during cell division (change in the cell program).
• Become a trigger of cascades of intracellular reactions, eventually leading to a change in the status of cell proliferation or differentiation in pathologically altered tissues.
• They can also stimulate the restoration and repair of cells in pathologically altered tissues.

The use of the bioregulator in patients with coronary heart disease reduced the number of angina attacks, reduced the manifestations of cardiac arrhythmias. In patients with arterial atherosclerosis, EPI-S improves general well-being and normalizes sleep. With hypertension, the drug in combination with antihypertensive drugs allows to achieve long-term remission.

EPI-S: clinical trials

Studies have confirmed the effectiveness of the drug in the complex prevention of vascular diseases in the elderly, as well as in the treatment and prevention of patients with atherosclerosis of the brain, heart vessels and lower extremities. EPI-S is also indicated for microcirculation disorders in organs and tissues and psycho-emotional stress.